Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Receivables - Other (2016 - 2024)

Historic Receivables - Other for Sanara MedTech (SMTI) over the last 13 years, with Q4 2024 value amounting to $1.1 million.

  • Sanara MedTech's Receivables - Other rose 213224.3% to $1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year increase of 213224.3%. This contributed to the annual value of $1.1 million for FY2024, which is 213224.3% up from last year.
  • Latest data reveals that Sanara MedTech reported Receivables - Other of $1.1 million as of Q4 2024, which was up 213224.3% from $1.1 million recorded in Q3 2024.
  • Sanara MedTech's Receivables - Other's 5-year high stood at $1.1 million during Q4 2024, with a 5-year trough of $49344.0 in Q1 2020.
  • Over the past 5 years, Sanara MedTech's median Receivables - Other value was $49344.0 (recorded in 2020), while the average stood at $179547.2.
  • Its Receivables - Other has fluctuated over the past 5 years, first plummeted by 7656.8% in 2023, then soared by 213224.3% in 2024.
  • Sanara MedTech's Receivables - Other (Quarter) stood at $49344.0 in 2020, then surged by 61.7% to $79787.0 in 2021, then rose by 24.82% to $99594.0 in 2022, then plummeted by 50.45% to $49344.0 in 2023, then skyrocketed by 2132.24% to $1.1 million in 2024.
  • Its Receivables - Other was $1.1 million in Q4 2024, compared to $1.1 million in Q3 2024 and $49344.0 in Q4 2023.